Patents - universities feel the pain.
This paper discusses the recent case of the University of Rochester vs. Searle that was presented at the Court of Appeals for the Federal Circuit. The case involved the patency of a new class of blockbuster drugs known as Cox-2 inhibitors, sold under such trademarks as Celebrex®, and Vioxx® which ar...
| Published in: | IEEE Engineering in medicine and biology magazine 23, 3 (2004). |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | English |
| Subjects: |